Unknown NA INTERVENTIONAL 2-arm NCT03280134

A Prospective Validation Cohort Study of a Prediction System on nSLN Metastasis in Early Breast Cancer

CK19 Combined With Contrast-enhanced Ultrasound for Predicting Non-sentinel Lymph Node Status in Early Breast Cancer: a Prospectively Validation Cohort Study of the Predictive Model

Sponsor: Zhejiang Cancer Hospital

Conditions Breast Cancer Lymph Node Metastases Predictive Cancer Model

Interventions axillary lymph node dissection (ALND)

Updated 7 times since 2017 Last updated: Jun 2, 2019 Started: Oct 15, 2018 Primary completion: Dec 31, 2019 Completion: Jun 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Breast Cancer and Lymph Node Metastases and is currently ongoing. Zhejiang Cancer Hospital leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Recruiting NA
Jul 2019 — Jan 2021 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 2 earlier versions

Jun 2018 — Jul 2019 [monthly]

Not Yet Recruiting NA
Oct 2017 — Jun 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zhejiang Cancer Hospital

Data source: Zhejiang Cancer Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hangzhou, China